Print

Meeting Reports and Materials

• Jan 27, 2010 Epidemiology of HIV Among MSM in Africa: Implications for rectal microbicides - AVAC and IRMA Listen as Chris Beyrer MD, MPH, Professor at Johns Hopkins Bloomberg School of Public Health, presents on the sobering HIV data among MSM in Africa and discuss serious challenges such as the lack of access to water-based lubricants.    more...  
• Dec 15, 2009 Advocates' briefing on results from the PRO 2000 microbicide MDP 301 study Following the Microbicides Development Programme's announcement the results of the MDP 301 study, the safety and effectivess of 0.5% PRO 2000, Global Campaign for Microbicides hosted a call to discuss the key findings of MDP 301. Visit GCM's website for more information and to download the...    more...  
• Dec 9, 2009 Community Perspectives on iPrEP Research: An Interactive Discussion of Issues & Opinions This teleconference is a continuation of the intermittent pre-exposure prophylaxis (iPrEP) conversation being organized by the Research Working Group of the PrEP Committee.    more...  
• Dec 4, 2009 Efficacy and Effectiveness - What is Good Enough? Who decides? Listen to a recorded discussion about efficacy and effectiveness of new prevention technologies. This call was sponsored by AVAC, Global Campaign for Microbicides and IRMA. Featured speakers* include Gus Cairns , Editor, HIV Treatment Update NAM Publications (Aidsmap); Dr Sheila Harvey ,...    more...  
• Oct 19, 2009 AIDS Vaccine 2009
  This year's AIDS Vaccine Conference—an annual gathering of researchers, funders and advocates to discuss the state of the field, new research discoveries and priorities for the year ahead—was held in Paris. Click the title of this meeting to view information on this year's conference and...    more...  
• Aug 23, 2009 Preparing for PrEP: A Stakeholder's Dialogue
  The UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS) and various partners convened a day-long dialogue in advance of the 2009 National HIV Prevention Conference (NHPC) to discuss PrEP research, the possible social and cultural implications of PrEP and also...    more...  
• Jul 19, 2009 The Promise and Perils of ARV-Based Prevention: A Dialogue of Optimism & Informed Skepticism
  AVAC and the International AIDS Society (IAS) co-organized a satellite session on ARV-based prevention at the IAS Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town. The session, The Promise and Perils of ARV-Based Prevention: A Dialogue of Optimism & Informed Skepticism,...    more...  
• Feb 19, 2009 CROI Distance Learning Series CHAMP and AVAC worked with partners to bring the information and dialogue from 2009 Conference on Retroviruses and Opportunistic Infections (CROI) conference to a much broader audience. This is a four-session series with webinars planned for February 19, February 26, March 5, March 12.    more...  
• Jan 14, 2009 AVAC Think Tank on PrEP Financing in the US
  Colleagues from multiple disciplines met for a one-day, AVAC-sponsored think tank examining how PrEP for HIV prevention might be funded or reimbursed through insurance mechanisms in the United States should it prove safe and effective. The think tank took forward discussions on PrEP...    more...  
• Dec 20, 2008 AVAC Think-Tank on Intermittent Dosing of PrEP
  In December 2008, AVAC held a one-day think tank where colleagues from multiple agencies and research disciplines discussed key scientific questions to be addressed in evaluating the merits of future prevention research on intermittent use of pre-exposure prophylaxis ("iPrEP") for prevention...    more...